Authors
Glushkov N.I., Zvyagintseva A.N., Horeva Yu.A., Atayeva A., Ivanov M.A.
NWSMU named after I.I. Mechnikov, St. Petersburg
Abstract
Rationale: The possibility of surgical intervention in patients with claudication determines the direction of treatment. At the same time, some patients are not characterized by a benign course of peripheral arterial disease. This work is based on clarifying the results of reconstructive treatment of patients with PAD at the stage of critical ischemia and in the case of stage IIb according to Pokrovsky — Fontaine.
Objective: analyze early postoperative complications and find an answer to the question: “Is stage IIb reconstruction justified in patients with PAD?”
Method: The study involved 237 patients who underwent reconstructive interventions for peripheral arterial disease. Of these, 136 patients were operated on at the CLI stage (critical limb ischemia — critical ischemia), and 101 patients received surgical assistance at the stage of claudication. The results of surgical interventions were prospectively assessed during the first 30 days after surgery and retrospectively analyzed. The primary end point was the development of complications (segment thrombosis, bleeding, surgical site infection).
Results: Patients treated surgically for stage CLI were more likely to experience early postoperative complications (thrombosis, infection, bleeding, and amputation). This is probably due to the more significant degree of arterial damage (multi-level damage) and the choice of surgical interventions.
Conclusion: The group of patients operated on at the stage of critical ischemia had a greater number of complications, therefore, in the case of an unfavorable development with a pronounced reduction in walking distance, the focus of tactical approaches should be changed towards active tactics, without waiting for the development of critical ischemia.
Keywords: peripheral arterial disease, critical ischemia, claudication.
References
1. Glushkov NI, Arutyunyan SO, Puzdryak PD, et al. Rol’ reabilitatsii v pozdnem posleoperatsionnom periode u bol’nykh s mnogourovnevym perifericheskim ateroskleroticheskim porazheniem. Sovremennye problemy nauki i obrazovaniya. 2023; 2. (In Russ.)
2. Glushkov NI, Potashov TA, Ivanov MA, et al. K voprosu ob optimal’nykh srokakh revaskulyarizatsii u lits s perifericheskim aterosklerozom. Profilakticheskaya i klinicheskaya meditsina. 2020; №3(76): 70-76. (In Russ.)
3. Glushkov NI, Puzdryak PD, Agurbash AN, et al. Gendernye osobennosti kriticheskoi ishemii nizhnikh konechnostei. Vestnik Severo- Zapadnogo gosudarstvennogo meditsinskogo universiteta im. I.I. Mechnikova. 2021; 13(4): 47-52. (In Russ.)
4. Glushkov NI, Puzdryak PD, Bondarenko PB, et al. Osobennosti programmy reabilitatsii v otdalennye sroki posle operativnogo lecheniya mnogourovnevykh porazhenii ateroskleroticheskogo geneza. Vestnik Natsional’nogo mediko-khirurgicheskogo tsentra im. N.I. Pirogova. 2020; 15(4). (In Russ.) doi: 10.25881/ BPNMSC.2020.91.28.011.
5. Ahimastos A, Walker PJ, Askew C, et al. Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: a randomized controlled trial. Jama. 2013. doi: 10.1001/jama.2012.216237.
6. Bouwens E, Klaphake S, Weststrate J, et al. Supervised exercise therapy and revascularization: Single-center experience of intermittent claudication management. Vasc Med. 2019. doi: 10.1177/1358863X18821175.
7. Cea-Soriano L, Fowkes F, Johansson S, et al. Time trends in peripheral artery disease incidence, prevalence and secondary preventive therapy: a cohort study in The Health Improvement Network in the UK. BMJ Open. 2019. doi: 10.1136/bmjopen-2017-018184.
8. Michael S, Conte, Frank B, et al. Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: Management of asymptomatic disease and claudication. 2015. doi: 10.1016/j.jvs.2014.12.009.
9. Curt D, Jens R, David P, et al. German Epidemiological Trial on Ankle Brachial Index Study Group. Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease. 2009. doi: 10.1161/CIRCULATIONAHA.109.865600.
10. Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). 2007. doi: 10.1016/j.ejvs.2006.09.024.
11. Emile R, William R, Mark A. Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease. 2007. doi: 10.1161/01.CIR.0000090686.57897.F5.
12. Rutherford RB, Baker JD, Ernst C, et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg. 1997. doi: 10.1016/s0741-5214(97)70045-4.
